Cebert Pharmaceuticals, Inc.
Tuesday, January 23, 2007

CEBERT PARTNERS WITH BRAND INSTITUTE TO BRAND UPCOMING PRODUCT

CONTACT: Jim Watkins

BIRMINGHAM, AL (January 23, 2007) -- Cebert Pharmaceuticals, Inc. announces it has enlisted the services of Brand Institute to name and brand it’s upcoming product indicated for anxiety and panic disorder.

This product has been in development with Cardinal Health since 2003 and will be ready for filing with the FDA by January 2008.

Brand Institute will be responsible for conducting all of the nomenclature research and creating a brand name for the new drug. It will then create a logo and any supplemental language and all design specifications which will accompany the new product. ‘Brand Institute has a long and successful history in branding products for our industry. We are excited to have them on board to begin this process,’ says Royce Watkins, Chairman and CEO.

Brand Institute is the premier full-service brand identity consultancy dedicated to the strategic and innovative development of brand naming and identity solutions. We strive to exceed the expectations of every client by combining leading-edge brand development with the highest levels of client service, integrity and expertise. Brand Institute recognizes each of our client's individual branding needs by developing customized approaches to each assignment. The results are strong brands developed through strategic planning, creative thinking and innovative global research capabilities. For more information, please visit our website at www.brandinstitute.com.

Headquartered in Dublin, Ohio, Cardinal Health, Inc. is an $80 billion, global company serving the health-care industry with products and services that help hospitals, physician offices and pharmacies reduce costs, improve safety, productivity and profitability, and deliver better care to patients. With a focus on making supply chains more efficient, reducing hospital-acquired infections and breaking the cycle of harmful medication errors, Cardinal Health develops market-leading technologies. The company also manufactures medical and surgical products and is one of the largest distributors of pharmaceuticals and medical supplies worldwide. Ranked No. 19 on the Fortune 500 and No. 1 in its sector on Fortune's ranking of Most Admired firms, Cardinal Health employs more than 40,000 people on five continents.

Cebert Pharmaceuticals, Inc. is a Birmingham, Alabama based pharmaceutical company which concentrates on the acquisition and/or licensing of existing proprietary products, along with the development of new, innovative products for a defined niche.